Skip to main content

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

GILD holding history

Gilead Sciences, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GILD overviewAll 13F holders of GILDFull Q2 2026 holdings

Shares (Q2 2026)
24,004,354
Value
$3.03B
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of GILD by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202624,004,354$3.03B0.2%+705,059+3.0%AddedHolders
Q1 202623,299,295$3.25B0.2%−213,439−0.9%ReducedHolders
Q4 202523,512,734$2.89B0.2%−222,042−0.9%ReducedHolders
Q3 202523,734,776$2.63B0.2%+899,667+3.9%AddedHolders
Q2 202522,835,109$2.53B0.2%+3,034,129+15.3%AddedHolders
Q1 202519,800,980$2.22B0.2%−269,483−1.3%ReducedHolders
Q4 202420,070,463$1.85B0.1%+2,821,905+16.4%AddedHolders
Q3 202417,248,558$1.45B0.1%−2,088,746−10.8%ReducedHolders
Q2 202419,337,304$1.33B0.1%+1,323,720+7.3%AddedHolders
Q1 202418,013,584$1.32B0.1%+211,866+1.2%AddedHolders
Q4 202317,801,718$1.44B0.1%+892,099+5.3%AddedHolders
Q3 202316,909,619$1.27B0.1%+158,794+0.9%AddedHolders
Q2 202316,750,825$1.29B0.1%+643,281+4.0%AddedHolders
Q1 202316,107,544$1.34B0.1%−1,089,406−6.3%ReducedHolders
Q4 202217,196,950$1.48B0.2%+1,780,489+11.5%AddedHolders
Q3 202215,416,461$951.0M0.1%−2,410,165−13.5%ReducedHolders
Q2 202217,826,626$1.10B0.1%+4,321,514+32.0%AddedHolders
Q1 202213,505,112$802.9M0.1%−2,124,284−13.6%ReducedHolders
Q4 202115,629,396$1.13B0.1%+229,768+1.5%AddedHolders
Q3 202115,399,628$1.08B0.1%+4,409,756+40.1%AddedHolders
Q2 202110,989,872$756.8M0.1%+1,702,366+18.3%AddedHolders
Q1 20219,287,506$600.3M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.